drugset / Trial / NCT03220113

Treatment of Chronic Migraine Headaches.

NCT03220113

Phase 1/2 Unknown 100 enrolled Corona Doctors Medical Clinics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is assessment of the safety and efficacy of the De-Novo therapy in the treatment of craniofacial neuralgia and migraine headaches.This is an open-label study of simultaneous administration of combination of dexamethasone, lidocaine, and thiamine into the trigeminal nerve branches as well as greater and lesser occipital nerve bilaterally in one session. Patients who meet the exclusion and inclusion criteria are eligible for trial if they have experienced chronic migraine and craniofacial pain not responding to other prior therapies.

Timeline

Start
2017-07-01
Primary completion
2018-07-01
Completion
2019-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 20 mg Other
Subject Lidocaine Other / unclassified 40 mg Other
Subject Thiamine Other / unclassified 100 mg Other